1 |
C-X-C motif chemokine ligand 8
(61 times)
|
Neoplasms (8 times)
|
IL-6 (10 times) IL (7 times) DEGs (6 times)
|
2016 CXCL8, IL-1beta and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients.
|
2 |
CXC chemokine ligand 8
(24 times)
|
Allergy and Immunology (7 times)
|
CCL2 (6 times) CXCR1 (3 times) CXCR3 (3 times)
|
2003 Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: characterization of antibody and chemokine binding sites.
|
3 |
C-X-C motif ligand 8
(15 times)
|
Neoplasms (3 times)
|
ELISA (3 times) CCL2 (2 times) CSE (2 times)
|
2013 Elastin sequences trigger transient proinflammatory responses by human dermal fibroblasts.
|
4 |
CXC ligand 8
(11 times)
|
Allergy and Immunology (2 times)
|
IL-8 (2 times) TNF-alpha (2 times) Bcl-2 (1 time)
|
2004 Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.
|
5 |
CXC chemokines including IL-8
(2 times)
|
Medicine (1 time)
|
DARC (1 time) NSCLC (1 time)
|
2004 Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis.
|
6 |
cysteine-x-cysteine ligand 8
(2 times)
|
Cell Biology (1 time)
|
Ab (1 time) bFGF (1 time) CXC (1 time)
|
2017 The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis.
|
7 |
capacity of Lmajor/Ltropica to modulate expression of IL-1beta, IL-8
(1 time)
|
Allergy and Immunology (1 time)
|
ACL (1 time) HC (1 time) MDMs (1 time)
|
2021 Differential inflammatory responses associated with Leishmania major and Ltropica in culture.
|
8 |
complexes of the chemokine interleukin-8
(1 time)
|
Biophysics (1 time)
|
---
|
2009 Probing hot spots on protein-protein interfaces with all-atom free-energy simulation.
|
9 |
construct blocked the production of the angiogenic ELR+CXC chemokines IL-8
(1 time)
|
Neoplasms (1 time)
|
HMVEC (1 time) PPARgamma (1 time) TRO (1 time)
|
2005 PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
|
10 |
CXCL7 or IL-8
(1 time)
|
Allergy and Immunology (1 time)
|
CTAP-III (1 time) CXCL (1 time) CXCL7 (1 time)
|
2002 Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
|
11 |
CXCR1 and 2 to interleukin 8
(1 time)
|
Neoplasms (1 time)
|
CR (1 time)
|
2012 Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells.
|
12 |
CXCR1, IL-8
(1 time)
|
Allergy and Immunology (1 time)
|
PI (1 time)
|
2006 Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals.
|
13 |
CXCR2 constitutively, STAT3 is phosphorylated upon stimulation with IL-8
(1 time)
|
Molecular Biology (1 time)
|
HMEC (1 time)
|
2005 KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway.
|
14 |
CXCR2, and displayed impaired chemotaxis towards IL-8
(1 time)
|
Tropical Medicine (1 time)
|
---
|
2012 Neutrophil paralysis in Plasmodium vivax malaria.
|
15 |
cysteine-X-cysteine motif ligand 8
(1 time)
|
Allergy and Immunology (1 time)
|
NCs (1 time)
|
2017 CXCL8 promotes the invasion of human osteosarcoma cells by regulation of PI3K/Akt signaling pathway.
|